Steno-occlusive carotid artery disease in the setting of acute ischemic stroke: to stent or not to stent?
Taylor
Robert A
RA
Zeenat Qureshi Stroke Research Center, University of Minnesota, Minneapolis, Minnesota 55455, USA. rataylor@umn.edu
Qureshi
Adnan I
AI
D000208:Acute Disease; D000800:Angioplasty, Balloon / Q000295:instrumentation*; D050197:Atherosclerosis / Q000150:complications* / Q000473:pathology / Q000628:therapy; D002545:Brain Ischemia / Q000150:complications* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000628:therapy; D002343:Carotid Artery, Internal / Q000473:pathology; D020215:Carotid Artery, Internal, Dissection / Q000150:complications* / Q000473:pathology; D016893:Carotid Stenosis / Q000150:complications* / Q000209:etiology / Q000473:pathology / Q000628:therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D020766:Intracranial Embolism / Q000150:complications* / Q000209:etiology / Q000473:pathology / Q000517:prevention & control; D018579:Patient Selection; D011994:Recombinant Proteins / Q000627:therapeutic use; D015607:Stents; D020521:Stroke / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator